FDA to Release Pfizer Data, But the Devil Could Be in the Details
Last month, the U.S. Food and Drug Administration (FDA) asked a Federal Court Judge to allow the agency 75 years to release all the data upon which it licensed Pfizer’s COVID-19 vaccine (Comirnaty). Earlier this month the FDA’s request was rejected. The drug regulator had originally stated that it could only produce 500 pages per […]
Sales of Pfizer COVID-19 Biologic for 2021-2022 May Near $70 Billion
Based on better than expected sales of its experimental messenger RNA (mRNA) BNT162b2 COVID-19 biologic, New York-based pharmaceutical company Pfizer, Inc. last summer revised projected sales of its experimental drug, also known as “Comirnaty,” from $26 billion to $33.5 billion in 2021. Characterizing second-quarter sales of BNT162b2 as “remarkable,” Pfizer’s chief executive officer (CEO) Albert […]
Study Finds SARS-CoV-2 Much Less Infectious After 20 Minutes in Air
A new study conducted by the University of Bristol Aerosol Research Centre in the United Kingdom found that the SARS-CoV-2 virus loses 90 percent of its virulence within 20 minutes after being exhaled into the air. Further, researchers concluded that the virus loses 50 percent of its ability to spread after only 10 minutes of […]
Testing Will Not Save Us
I have heard many people say that at this moment—January 2022—testing will save us. They cite success stories like the National Basketball Association’s bubble (of 2020) to show what testing can accomplish. Unfortunately, here are nine considerations that they are missing when it comes to mass testing. 1. No one has any tests. There are […]
Explaining the Supreme Court’s Decision to Block Vaccine Mandate
The Supreme Court of the United States blocked President Biden’s vaccine mandate for large private businesses. But in a separate case, the court ruled that the mandate for health care workers at facilities which receive federal funds will stand. Companies with 100 or more employees, large companies… the mandate required all employees in those firms […]
Are Adverse Events in COVID-19 Vaccine Trials Under-Reported?
Phase III controlled trials are considered the ‘gold standard’ for assessing vaccine efficacy and safety in humans. These are the trials upon which authorities have assured the public that COVID-19 vaccines are “safe and effective.” The benefits of the vaccines in reducing disease severity and hospitalizations are well-known, but what do we know about the adverse events?Data on adverse events is vital for effective decision-making by regulators, policy makers, doctors, and patients.
